Table 3.

Clinical outcomes compared between the groups with and without chronic kidney disease during follow‐up period

	Non‐CKD group (N = 192)	CKD group (N = 70)	p Value	Unadjusted HR (95% CI)	p Value	Adjusted HR (95% CI)	p Value
Composite outcome (MACEs)	43 (22.4%)	29 (41.4%)	.003	1.78 (1.11–2.85)	.017	1.71 (1.11–2.62)	.015
Hospitalization for heart failure	22 (11.5%)	26 (37.1%)	<.001	3.35 (1.90–5.93)	<.001	2.30 (1.16–4.55)	.017
Cardiac death	5 (2.6%)	7 (10.0%)	.018	1.78 (1.17–2.85)	.017	4.10 (1.02–16.41)	.046
Myocardial infarction	8 (4.2%)	3 (4.3%)	1.00	1.03 (0.27–3.89)	.96	0.56 (0.11–2.89)	.49
Aortic valve replacement	14 (7.3%)	2 (2.9%)	.25	0.35 (0.08–1.56)	.17	1.41 (0.26–7.64)	.69

Note: MACEs included cardiac death, myocardial infarction, hospitalization for heart failure, and aortic valve replacement.

Adjusted by age, sex, pulse pressure, hypertension, diabetes mellitus, hyperlipidemia, cerebrovascular accident, atrial fibrillation, and eʹ velocity.

Abbreviations: CI, confidence interval; CKD, chronic kidney disease; HR, hazard ratio; MACEs, major adverse cardiac events.